T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.96B |
| 3 |
Global Payments
GPN
|
+$1.95B |
| 4 |
Salesforce
CRM
|
+$1.48B |
| 5 |
Boeing
BA
|
+$1.47B |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.45B |
| 5 |
Pfizer
PFE
|
+$1.22B |
Sector Composition
| 1 | Technology | 19.69% |
| 2 | Healthcare | 15.84% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
1126
Community Healthcare Trust
CHCT
$445M
| $21.5M | ﹤0.01% |
481,648
+1,413
| +0.3% | +$62.9K |
|
1127
Ponce Financial Group
PDLB
$336M
| $21.4M | ﹤0.01% |
2,126,955
+503
| +0% | +$5.07K |
|
1128
Pinnacle West Capital
PNW
$10.5B
| $21.3M | ﹤0.01% |
219,742
+1,341
| +0.6% | +$130K |
|
|
ZGNX
1129
DELISTED
Zogenix, Inc.
ZGNX
| $21.3M | ﹤0.01% |
531,058
-289,091
| -35% | -$11.6M |
|
1130
Garmin
GRMN
$45.8B
| $21.2M | ﹤0.01% |
250,555
+48,495
| +24% | +$4.11M |
|
1131
Mohawk Industries
MHK
$8.45B
| $21.2M | ﹤0.01% |
170,939
-13,482
| -7% | -$1.67M |
|
1132
Apellis Pharmaceuticals
APLS
$3.14B
| $21.1M | ﹤0.01% |
874,412
+175,200
| +25% | +$4.22M |
|
1133
Southern First Bancshares
SFST
$366M
| $21.1M | ﹤0.01% |
528,493
+6,019
| +1% | +$240K |
|
1134
Orion
OEC
$521M
| $21M | ﹤0.01% |
1,255,507
+24,274
| +2% | +$406K |
|
1135
Supernus Pharmaceuticals
SUPN
$2.55B
| $20.9M | ﹤0.01% |
759,625
-12,160
| -2% | -$334K |
|
1136
Culp
CULP
$59.5M
| $20.8M | ﹤0.01% |
1,275,881
-331,040
| -21% | -$5.4M |
|
1137
TETRA Technologies
TTI
$630M
| $20.8M | ﹤0.01% |
10,334,424
+167,549
| +2% | +$337K |
|
|
LDL
1138
DELISTED
Lydall, Inc.
LDL
| $20.6M | ﹤0.01% |
828,640
-3,883
| -0.5% | -$96.7K |
|
|
LOGM
1139
DELISTED
LogMein, Inc.
LOGM
| $20.6M | ﹤0.01% |
290,476
+5,084
| +2% | +$361K |
|
1140
Barings BDC
BBDC
$978M
| $20.5M | ﹤0.01% |
2,016,320
-18,590
| -0.9% | -$189K |
|
1141
Everest Group
EG
$14.7B
| $20.4M | ﹤0.01% |
76,683
-724
| -0.9% | -$193K |
|
1142
Regenxbio
RGNX
$465M
| $20.4M | ﹤0.01% |
572,958
-88,341
| -13% | -$3.14M |
|
1143
Stepan Co
SCL
$1.09B
| $20.2M | ﹤0.01% |
208,266
+8,487
| +4% | +$824K |
|
1144
Jack Henry & Associates
JKHY
$11.7B
| $20.1M | ﹤0.01% |
137,687
-161,519
| -54% | -$23.6M |
|
1145
Diageo
DEO
$56.5B
| $19.9M | ﹤0.01% |
121,535
+2,527
| +2% | +$413K |
|
1146
Molson Coors Class B
TAP
$9.57B
| $19.8M | ﹤0.01% |
344,820
+723
| +0.2% | +$41.6K |
|
1147
Natera
NTRA
$23.1B
| $19.7M | ﹤0.01% |
601,748
-240,720
| -29% | -$7.9M |
|
|
VAR
1148
DELISTED
Varian Medical Systems, Inc.
VAR
| $19.7M | ﹤0.01% |
165,438
-4,588
| -3% | -$546K |
|
1149
REV Group
REVG
$3.02B
| $19.6M | ﹤0.01% |
1,718,501
-96,075
| -5% | -$1.1M |
|
|
CISN
1150
DELISTED
Cision Ltd. Ordinary Share
CISN
| $19.6M | ﹤0.01% |
2,549,802
-756,465
| -23% | -$5.82M |
|